Incyte Corp.

NASDAQ: INCY    
Share price (4/23/24): $51.65    
Market cap (4/23/24): $11.6 billion
Search in Documents
Key Exhibits
External Links
9 Incyte Corp. Expert Interviews, now on BamSEC.
 Powered by Tegus.

Indentures Filter

EX-4.3
from 10-K 2 pages Incyte Corporation Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-3ASR 52 pages Incyte Corporation to [ ] Trustee Indenture Dated as of , 20 Incyte Corporation Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of , 20
12/34/56
EX-4.2
from 8-K 111 pages Incyte Corporation and U.S. Bank National Association, as Trustee Indenture Dated as of November 14, 2013 1.25% Convertible Senior Notes Due 2020
12/34/56
EX-4.1
from 8-K 111 pages Incyte Corporation and U.S. Bank National Association, as Trustee Indenture Dated as of November 14, 2013 0.375% Convertible Senior Notes Due 2018
12/34/56
EX-4.1
from 8-K 103 pages Incyte Corporation 4.75% Convertible Senior Notes Due 2015 Indenture Dated as of September 30, 2009 U.S. Bank National Association, as Trustee
12/34/56
EX-4.3.2
from 10-K ~1 page Date Issued Name of Note Holder Principal Amount Initial Conversion Price Maturity Date February 3, 2006 Pfizer Ireland Pharmaceuticals(1) $ 10,000,000 $ 6.8423 February 3, 2013 October 10, 2007 Pfizer Inc. $ 10,000,000 $ 9.75 October 10, 2014 (1) Formerly Known as Pfizer Overseas Pharmaceuticals
12/34/56
EX-4.1
from POSASR 55 pages Incyte Corporation to [ ]
12/34/56
EX-4
from SC 13D/A 1 page Agreement
12/34/56
EX-4.2
from 8-A12B/A 2 pages Amendment No. 1 to Rights Agreement
12/34/56
EX-4.4.2
from 10-K 2 pages Date Issued Name of Note Holder Principal Amount Initial Conversion Price Maturity Date February 3, 2006 Pfizer Ireland Pharmaceuticals(1) $ 10,000,000 $ 6.8423 February 3, 2013 October 10, 2007 Pfizer Inc. $ 10,000,000 $ 9.75 October 10, 2014 (1) Formerly Known as Pfizer Overseas Pharmaceuticals
12/34/56
EX-4
from SC 13D/A 1 page Agreement
12/34/56
EX-4
from SC 13D/A 1 page Agreement
12/34/56
EX-4
from SC 13D/A 1 page Agreement
12/34/56
EX-4
from SC 13D/A 2 pages Agreement
12/34/56
EX-4
from SC 13D/A 2 pages Agreement
12/34/56
EX-4
from SC 13D/A 1 page Agreement
12/34/56
EX-4.2
from 8-K 24 pages Registration Rights Agreement Dated as of September 26, 2006 Between Incyte Corporation and Piper Jaffray & Co
12/34/56
EX-4.1
from 8-K 91 pages Incyte Corporation to U.S. Bank National Association, as Trustee Indenture Dated as of September 26, 2006 3½% Convertible Senior Notes Due 2011
12/34/56
EX-4.1
from 8-K/A 33 pages Incyte Corporation Convertible Subordinated Promissory Note
12/34/56
EX-4.2
from S-3 26 pages Registration Rights Agreement Dated as of February 19, 2004 Between Incyte Corporation and Morgan Stanley & Co. Incorporated, as Representative of the Initial Purchasers
12/34/56